Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Development of a Universal Influenza Vaccine.

Estrada LD, Schultz-Cherry S.

J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. Review.

PMID:
30617121
2.

The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Ağaç D, Estrada LD, Maples R, Hooper LV, Farrar JD.

Brain Behav Immun. 2018 Nov;74:176-185. doi: 10.1016/j.bbi.2018.09.004. Epub 2018 Sep 5.

PMID:
30195028
3.

Functionalization of stable fluorescent nanodiamonds towards reliable detection of biomarkers for Alzheimer's disease.

Morales-Zavala F, Casanova-Morales N, Gonzalez RB, Chandía-Cristi A, Estrada LD, Alvizú I, Waselowski V, Guzman F, Guerrero S, Oyarzún-Olave M, Rebolledo C, Rodriguez E, Armijo J, Bhuyan H, Favre M, Alvarez AR, Kogan MJ, Maze JR.

J Nanobiotechnology. 2018 Aug 10;16(1):60. doi: 10.1186/s12951-018-0385-7.

4.

The cluster [Re6Se8I6]3- penetrates biological membranes: drug-like properties for CNS tumor treatment and diagnosis.

Estrada LD, Duran E, Cisterna M, Echeverria C, Zheng Z, Borgna V, Arancibia-Miranda N, Ramírez-Tagle R.

Biometals. 2018 Aug;31(4):517-525. doi: 10.1007/s10534-018-0097-3. Epub 2018 Mar 24.

PMID:
29574625
5.

Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease.

Estrada LD, Oliveira-Cruz L, Cabrera D.

Curr Protein Pept Sci. 2018;19(12):1180-1188. doi: 10.2174/1389203719666171129094937.

PMID:
29189146
6.

Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.

Estrada LD, Chamorro D, Yañez MJ, Gonzalez M, Leal N, von Bernhardi R, Dulcey AE, Marugan J, Ferrer M, Soto C, Zanlungo S, Inestrosa NC, Alvarez AR.

J Alzheimers Dis. 2016 Oct 4;54(3):1193-1205.

PMID:
27567806
7.

c-Abl links APP-BACE1 interaction promoting APP amyloidogenic processing in Niemann-Pick type C disease.

Yáñez MJ, Belbin O, Estrada LD, Leal N, Contreras PS, Lleó A, Burgos PV, Zanlungo S, Alvarez AR.

Biochim Biophys Acta. 2016 Nov;1862(11):2158-2167. doi: 10.1016/j.bbadis.2016.08.016. Epub 2016 Aug 23.

8.

Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function.

Estrada LD, Ağaç D, Farrar JD.

Eur J Immunol. 2016 Aug;46(8):1948-58. doi: 10.1002/eji.201646395. Epub 2016 Jun 8.

9.

STAT4-mediated transcriptional repression of the IL5 gene in human memory Th2 cells.

Gonzales-van Horn SR, Estrada LD, van Oers NS, Farrar JD.

Eur J Immunol. 2016 Jun;46(6):1504-10. doi: 10.1002/eji.201546050. Epub 2016 Apr 8.

10.

c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's disease.

Gonzalez-Zuñiga M, Contreras PS, Estrada LD, Chamorro D, Villagra A, Zanlungo S, Seto E, Alvarez AR.

Mol Cell. 2014 Oct 2;56(1):163-73. doi: 10.1016/j.molcel.2014.08.013. Epub 2014 Sep 11.

11.

EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers.

Vargas LM, Leal N, Estrada LD, González A, Serrano F, Araya K, Gysling K, Inestrosa NC, Pasquale EB, Alvarez AR.

PLoS One. 2014 Mar 21;9(3):e92309. doi: 10.1371/journal.pone.0092309. eCollection 2014.

12.

Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.

Chowdhury FZ, Estrada LD, Murray S, Forman J, Farrar JD.

PLoS One. 2014 Mar 18;9(3):e92187. doi: 10.1371/journal.pone.0092187. eCollection 2014.

13.

Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease.

Moreno-Gonzalez I, Estrada LD, Sanchez-Mejias E, Soto C.

Nat Commun. 2013;4:1495. doi: 10.1038/ncomms2494.

PMID:
23422663
14.

De novo induction of amyloid-β deposition in vivo.

Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C.

Mol Psychiatry. 2012 Dec;17(12):1347-53. doi: 10.1038/mp.2011.120. Epub 2011 Oct 4.

PMID:
21968933
15.

C-Abl tyrosine kinase signaling: a new player in AD tau pathology.

Estrada LD, Zanlungo SM, Alvarez AR.

Curr Alzheimer Res. 2011 Sep;8(6):643-51. Review.

PMID:
21605041
16.

Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.

Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C.

J Neurosci. 2010 Mar 31;30(13):4528-35. doi: 10.1523/JNEUROSCI.5924-09.2010.

17.

Protein misfolding and neurodegeneration.

Soto C, Estrada LD.

Arch Neurol. 2008 Feb;65(2):184-9. doi: 10.1001/archneurol.2007.56. Review.

PMID:
18268186
18.

Disrupting beta-amyloid aggregation for Alzheimer disease treatment.

Estrada LD, Soto C.

Curr Top Med Chem. 2007;7(1):115-26.

PMID:
17266599
19.

Protein misfolding disorders and rational design of antimisfolding agents.

Estrada LD, Yowtak J, Soto C.

Methods Mol Biol. 2006;340:277-93. Review.

PMID:
16957342
20.

Inhibition of protein misfolding and aggregation by small rationally-designed peptides.

Estrada LD, Soto C.

Curr Pharm Des. 2006;12(20):2557-67. Review.

PMID:
16842178

Supplemental Content

Loading ...
Support Center